We are live on ! Find out more
EARNEST Partners

EARNEST Partners Portfolio holdings

AUM $27.7B
1-Year Est. Return 52.44%
This Fund
S&P 500
This Quarter Est. Return
+30.37%
1 Year Est. Return
+52.44%
3 Year Est. Return
+92.17%
5 Year Est. Return
+120.28%
10 Year Est. Return
+519.8%
AUM
$14.5B
AUM Growth
+$2.88B
Cap. Flow
-$198M
Cap. Flow %
-1.37%
Top 10 Hldgs %
16.33%
Holding
1,216
New
16
Increased
105
Reduced
134
Closed
10

Top Buys

Rank Stock Value
1
MD icon
Pediatrix Medical
MD
+$111M
2
AROC icon
Archrock
AROC
+$56.8M
3
CBRL icon
Cracker Barrel
CBRL
+$46.8M
4
SABR icon
Sabre
SABR
+$46.5M
5
CNMD icon
CONMED
CNMD
+$43.5M

Sector Composition

Rank Sector Weight
1 Technology 21.74%
2 Financials 18.46%
3 Industrials 17.49%
4 Healthcare 12.3%
5 Consumer Discretionary 10.95%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
LFUS icon
26
Littelfuse
LFUS
$10.3B
$152M 1.05%
596,149
+4,538
+0.8% +$1M
SANM icon
27
Sanmina
SANM
$10.4B
$151M 1.04%
4,726,748
+7,473
+0.2% +$222K
MD icon
28
Pediatrix Medical
MD
$2.16B
$146M 1.01%
5,936,652
+5,936,615
+16,044,905% +$111M
MOH icon
29
Molina Healthcare
MOH
$10.4B
$142M 0.98%
669,027
+8,533
+1% +$1.76M
AIMC
30
DELISTED
Altra Industrial Motion Corp
AIMC
$142M 0.98%
2,558,314
+24,913
+1% +$1.23M
MANT
31
DELISTED
Mantech International Corp
MANT
$140M 0.97%
1,579,049
+15,313
+1% +$1.16M
HMN icon
32
Horace Mann Educators
HMN
$2.08B
$134M 0.93%
3,195,717
+931,740
+41% +$35.9M
SNPS icon
33
Synopsys
SNPS
$84.8B
$134M 0.92%
515,201
-17,477
-3% -$4.03M
RIO icon
34
Rio Tinto
RIO
$168B
$133M 0.92%
1,773,479
+51,950
+3% +$3.41M
MYGN icon
35
Myriad Genetics
MYGN
$302M
$133M 0.92%
6,731,429
+1,785,819
+36% +$28.8M
ENS icon
36
EnerSys
ENS
$6.69B
$130M 0.9%
1,570,502
+14,242
+0.9% +$1.12M
HDB icon
37
HDFC Bank
HDB
$119B
$129M 0.89%
3,558,308
-737,346
-17% -$23.5M
CDP icon
38
COPT Defense Properties
CDP
$4.15B
$128M 0.88%
4,908,182
+1,082,701
+28% +$27.3M
BBD icon
39
Banco Bradesco
BBD
$34.4B
$127M 0.88%
29,285,534
-1,405,715
-5% -$5.14M
EBS icon
40
Emergent Biosolutions
EBS
$303M
$125M 0.86%
1,390,735
-4,059
-0.3% -$373K
CBT icon
41
Cabot Corp
CBT
$4.32B
$124M 0.86%
2,765,328
+64,096
+2% +$2.66M
CBRE icon
42
CBRE Group
CBRE
$43.7B
$123M 0.85%
1,965,381
-60,158
-3% -$3.4M
STAG icon
43
STAG Industrial
STAG
$7.17B
$123M 0.85%
3,916,820
-8,323
-0.2% -$260K
MTH icon
44
Meritage Homes
MTH
$4.63B
$121M 0.83%
2,911,148
-772
-0% -$36.5K
IBN icon
45
ICICI Bank
IBN
$107B
$120M 0.83%
8,068,835
-864,340
-10% -$10.9M
PEB icon
46
Pebblebrook Hotel Trust
PEB
$2.09B
$119M 0.82%
6,343,190
-18,881
-0.3% -$306K
ICLR icon
47
Icon
ICLR
$13.1B
$117M 0.81%
600,570
+14,170
+2% +$2.77M
AEIS icon
48
Advanced Energy
AEIS
$10.9B
$115M 0.79%
1,185,257
-10,081
-0.8% -$858K
CLB icon
49
Core Laboratories
CLB
$567M
$113M 0.78%
4,266,748
+83,652
+2% +$1.71M
DRI icon
50
Darden Restaurants
DRI
$24.5B
$113M 0.78%
948,968
-79,679
-8% -$8.53M

Similar funds

EARNEST Partners's Q4 2020 Portfolio in Review

As of Q4 2020, EARNEST Partners held 1,216 positions worth $14.5B, up 25% from $11.6B the previous quarter. Its ten largest holdings account for 16% of the portfolio.

Trading was light in Q4 2020: portfolio turnover was 2.1%. EARNEST Partners opened 16 new positions and exited 10, leaving the 1,216-position portfolio largely intact.

By sector, the portfolio is most concentrated in Technology at 22% of assets, down from 23% a quarter earlier, followed by Financials and Industrials.

  • EARNEST Partners's largest Q4 2020 buy was TTM Technologies: 400,909 shares worth $5.53M.
  • EARNEST Partners added most to Pediatrix Medical in Q4 2020, an estimated $111M increase.
  • EARNEST Partners's biggest Q4 2020 reduction was American Equity Investment Life Holding Company, cutting an estimated $94.4M.
  • EARNEST Partners fully exited Immunomedics Inc in Q4 2020, selling an estimated $10K.
  • EARNEST Partners's ten largest holdings make up 16% of its $14.5B portfolio in Q4 2020.
  • EARNEST Partners opened 16 new positions and closed 10 in Q4 2020.
  • EARNEST Partners's portfolio value rose 25% quarter-over-quarter to $14.5B.

Based on EARNEST Partners's 13F filing for Q4 2020, filed 16 Feb 2021.